Fexapotide structure
|
Common Name | Fexapotide | ||
|---|---|---|---|---|
| CAS Number | 492447-54-8 | Molecular Weight | 2055.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C90H163N27O25S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FexapotideFexapotide (NX-1207 free acid) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research[1][2][3]. |
| Name | Fexapotide |
|---|
| Description | Fexapotide (NX-1207 free acid) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research[1][2][3]. |
|---|---|
| Related Catalog |
| Molecular Formula | C90H163N27O25S |
|---|---|
| Molecular Weight | 2055.49 |
| InChIKey | BROGCIMRGWLMOO-SJPGHYFNSA-N |
| SMILES | CCC(C)C(N)C(=O)NC(CC(=O)O)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CC(C)C)C(=O)O)C(C)CC)C(C)CC)C(C)C |